i
i
Up-to-date Information
Up-to-Date Info: To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-nCoV/index.html
COVID-19 vaccine breakthrough case investigation : information for state and local health departments
-
April 15, 2021
Details:
-
Corporate Authors:
-
Description:Objective: Investigate SARS-CoV-2 infections among people who received COVID-19 vaccine to identify trends or clustering in demographics, the administered vaccine, or the infecting virus.
Case definition: A person who has SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after they completed the primary series of an FDA-authorized COVID-19 vaccine.
Exclusion criteria: The person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected <45 days before the most recent positive test.
Publication date from document properties.
Information-for-State-and-Local-Health-Departments-COVID-19-vaccine-breakthrough-case-investigation.pdf
-
Subjects:
-
Document Type:
-
Genre:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:
-
File Type:
Supporting Files
-
No Additional Files
More +